Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia
NCT03624270
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Acute Promyelocytic Leukemia
Interventions
DRUG:
Oral arsenic Trioxide, ATRA and ascorbic acid
Sponsor
The University of Hong Kong